Clinical Trial Update: Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update describes an intercalated regimen of chemotherapy and tyrosine kinase inhibitors as first-line treatment for Non-Small-Cell Lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Intercalated chemotherapy + tyrosine kinase inhibitors

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Non-Small-Cell Lung Cancer | Phase 4 | Status: UNKNOWN